We present initial results of a clinical trial involving breast cancer patients under neoadjuvant chemotherapy, monitored through our time-resolved optical mammograph. Besides hemoglobin, water and lipids, we assess collagen concentration systematically for the first time.
Preliminary Evidence of the Efficacy of Time-Resolved Broad-Spectrum Optical Mammography in Monitoring Neoadjuvant Chemotherapy
Maffeis G.;Mule N.;Cubeddu R.;Pifferi A.;Taroni P.
2022-01-01
Abstract
We present initial results of a clinical trial involving breast cancer patients under neoadjuvant chemotherapy, monitored through our time-resolved optical mammograph. Besides hemoglobin, water and lipids, we assess collagen concentration systematically for the first time.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Maffeis_BIOMED_Translational-2022-JM3A.28_non editorial_rev.pdf
accesso aperto
:
Post-Print (DRAFT o Author’s Accepted Manuscript-AAM)
Dimensione
265.88 kB
Formato
Adobe PDF
|
265.88 kB | Adobe PDF | Visualizza/Apri |
|
Maffeis_BIOMED_Translational-2022-JM3A.28_rev.pdf
Accesso riservato
:
Publisher’s version
Dimensione
290.93 kB
Formato
Adobe PDF
|
290.93 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
